Background—Pulmonary diffusing capacity for carbon monoxide (Dlco), alveolar capillary membrane diffusing capacity (Dm), and pulmonary capillary blood volume (Vc) are all significantly reduced after ...
MyChesCo on MSN12d
Savara Inc. Publishes Promising Long-Term Outcomes for aPAP TreatmentLANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced the publication of a manuscript detailing long-term outcomes for molgramostim inhalation solution in patients with autoimmune pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback